Market Cap

InVivo Therapeutics Holdings Corp. Market Capitalization:

$2.4 Million

USD as of Jan. 1, 2024

business InVivo Therapeutics Holdings Corp. Company Profile

InVivo Therapeutics Holdings Corp. Main Stock Listing

NASDAQ: NVIV

Market Capitalization History of InVivo Therapeutics Holdings Corp.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of InVivo Therapeutics Holdings Corp. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $2.4 M -46.40%
Jan. 1, 2023 $4.5 M -75.79%
Jan. 1, 2022 $18.7 M -66.67%
Jan. 1, 2021 $56.0 M -83.75%
Jan. 1, 2020 $344.7 M -85.88%
Jan. 1, 2019 $2.44 B -87.17%
Jan. 1, 2018 $19.03 B -88.84%
Jan. 1, 2017 $170.55 B 7.22%
Jan. 1, 2016 $159.06 B -43.49%
Jan. 1, 2015 $281.50 B -10.91%
Jan. 1, 2014 $315.97 B 6.80%
Jan. 1, 2013 $295.86 B -8.44%
Jan. 1, 2012 $323.15 B 27.84%
Jan. 1, 2011 $252.78 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

InVivo Therapeutics Holdings Corp. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

InVivo Therapeutics Holdings Corp. has the following listings and related stock indices.


Stock: NASDAQ: NVIV

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.